<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75-pharmaceuticals-13-00096">
 <label>75.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Verstovsek</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kantarjian</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Mesa</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Pardanani</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Cortes-Franco</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Thomas</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Estrov</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Fridman</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Bradley</surname>
    <given-names>E.C.</given-names>
   </name>
   <name>
    <surname>Erickson-Viitanen</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2010</year>
  <volume>363</volume>
  <fpage>1117</fpage>
  <lpage>1127</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1002028</pub-id>
  <?supplied-pmid 20843246?>
  <pub-id pub-id-type="pmid">20843246</pub-id>
 </element-citation>
</ref>
